Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.

Front Immunol · 2025 · PMC12226472 · PMID 40621463

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A similar trend was observed in patients with non-small cell lung cancer, where the presence of ir-thyroid disorders was associated with numerically longer survival, although the difference did not reach statistical significance ( 17 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.